Biotron Limited Stock Performance
BITRF Stock | USD 0.06 0.00 0.00% |
Biotron has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.3, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biotron's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotron is expected to be smaller as well. Biotron Limited right now shows a risk of 5.95%. Please confirm Biotron Limited sortino ratio and the relationship between the potential upside and day typical price , to decide if Biotron Limited will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biotron Limited are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Biotron may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Begin Period Cash Flow | 4.2 M |
Biotron |
Biotron Relative Risk vs. Return Landscape
If you would invest 5.98 in Biotron Limited on January 20, 2024 and sell it today you would lose (0.13) from holding Biotron Limited or give up 2.17% of portfolio value over 90 days. Biotron Limited is currently producing 0.1366% returns and takes up 5.9481% volatility of returns over 90 trading days. Put another way, 52% of traded pink sheets are less volatile than Biotron, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Biotron Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotron's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Biotron Limited, and traders can use it to determine the average amount a Biotron's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.023
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | BITRF | Huge Risk |
Negative Returns |
Estimated Market Risk
5.95 actual daily | 52 52% of assets are less volatile |
Expected Return
0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biotron is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotron by adding it to a well-diversified portfolio.
Biotron Fundamentals Growth
Biotron Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Biotron, and Biotron fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotron Pink Sheet performance.
Return On Equity | -1.12 | |||
Return On Asset | -0.56 | |||
Profit Margin | (1.78) % | |||
Operating Margin | (1.78) % | |||
Current Valuation | 15.31 M | |||
Shares Outstanding | 901.94 M | |||
Price To Earning | (3.04) X | |||
Price To Book | 23.61 X | |||
Price To Sales | 11.17 X | |||
Revenue | 1.56 M | |||
EBITDA | (2.73 M) | |||
Cash And Equivalents | 1.74 M | |||
Total Debt | 77.24 K | |||
Debt To Equity | 0.07 % | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (2.44 M) | |||
Earnings Per Share | (0) X | |||
Total Asset | 1.91 M | |||
Retained Earnings | (37 M) | |||
Current Asset | 3 M | |||
About Biotron Performance
To evaluate Biotron Limited Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Biotron generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Biotron Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Biotron Limited market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Biotron's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Biotron Limited performance evaluation
Checking the ongoing alerts about Biotron for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Biotron Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Biotron Limited had very high historical volatility over the last 90 days | |
Biotron Limited has some characteristics of a very speculative penny stock | |
The company reported the revenue of 1.56 M. Net Loss for the year was (2.78 M) with profit before overhead, payroll, taxes, and interest of 1.56 M. | |
Biotron Limited has accumulated about 1.74 M in cash with (2.44 M) of positive cash flow from operations. | |
Roughly 14.0% of the company shares are held by company insiders |
- Analyzing Biotron's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotron's stock is overvalued or undervalued compared to its peers.
- Examining Biotron's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotron's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotron's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biotron's pink sheet. These opinions can provide insight into Biotron's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotron Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Biotron Pink Sheet analysis
When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |